YOLFTbeta
Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc. Common Stock

TELO · NASDAQ · Healthcare / Biotechnology

0.4906USD-0.01 (-1.96%)

Price History

Full chart

Market Stats

Previous Close0.5004
Open0.4924
Day Range0.4882 – 0.5717
52-Week Range0.888 – 2.09
Volume124.26K
Market Cap82.53M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.10
Dividend Yield0.00%
Beta-0.25
50-Day Avg1.16
200-Day Avg1.26

About

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Erez Aminov
  • Employees0
  • Headquarters100 SE 2nd Street, Miami, FL, United States, 33131, USA
  • Websitehttps://telomirpharma.com

Leadership

  • Mr. Erez AminovChairman of the Board & CEO · b. 1978
  • Mr. Andriy Mushak CPAChief Financial Officer · b. 1983
  • Dr. Itzchak Angel Ph.D.Chief Scientific Advisor

Financials

Income Statement

Currency: USD2021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue00000
Cost of Revenue--3.94M--
Gross Profit---3.94M--
Operating Expense--0--
Operating Income-138.13K-854.15K-3.94M-12.24M-10.54M
EBITDA-138.13K-854.15K-11.43M48.00K-10.41M
Net Income-138.13K-854.15K-13.07M-16.53M-10.41M
R&D126.49K833.21K1.57M2.24M2.44M
Interest Expense-01.64M4.34M0

Balance Sheet

Currency: USD2021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets55.00K48.73K4.77M1.32M7.34M
Total Liabilities138.13K986.01K1.34M680.97K1.43M
Total Equity-83.13K-937.28K3.44M643.04K5.91M
Cash01.42K1.23K1.27M7.29M
Total Debt119.40K581.79K101.00K93.43K473.75K
Net Debt119.40K-1.42K99.77K-1.17M-6.81M

Cash Flow

Currency: USD2021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-119.40K-468.66K-3.86M-5.07M-3.69M
Financing Cash Flow119.40K470.08K3.86M6.34M9.71M
Capital Expenditure40400
Free Cash Flow-119.40K-468.66K-3.86M-5.07M-3.69M
FCF to OCF100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateMar 31, 2024Aug 13, 2024Nov 11, 2024Feb 4, 2025May 14, 2025Aug 14, 2025Nov 10, 2025Feb 25, 2026May 12, 2026Aug 13, 2026Nov 9, 2026
EPS Estimate----0.05-0.10-0.08-0.07----
EPS Actual-0.23-0.05-0.20-0.10-0.07-0.17-0.03-0.06-0.03-0.79-
Surprise----100.00%30.00%-112.50%57.14%----
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hours--

Key Statistics & Ratios

Market Cap82.53M
Enterprise Value79.42M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book16.81
EPS-1.10
Book Value0.144
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-213.10%
Return on Assets-122.81%
Shares Outstanding68.77M
Shares Float45.73M
Beta-0.25
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
4.31%
Insiders
46.00%
Retail / Other
49.69%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    995.37K1.45%
  • BlackRock Inc
    289.20K0.42%
  • Geode Capital Management, LLC
    249.09K0.36%
  • Vanguard Fiduciary Trust Co
    135.54K0.20%
  • State Street Corp
    58.60K0.09%
  • Bank of New York Mellon Corp
    51.45K0.07%
  • Northern Trust Corp
    41.84K0.06%
  • Pensionmark Financial Group, LLC
    37.04K0.05%
  • XTX Topco Ltd
    36.06K0.05%
  • Advisor Group Holdings, Inc.
    35.80K0.05%
  • Resources Investment Advisors Inc
    23.00K0.03%
  • Praetorian Wealth Management Inc
    20.00K0.03%
  • Citadel Advisors Llc
    13.27K0.02%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.12M1.63%
  • Fidelity Extended Market Index
    210.40K0.31%
  • iShares Micro-Cap ETF
    36.93K0.05%
  • Fidelity Series Total Market Index
    36.55K0.05%
  • Fidelity Total Market Index
    30.10K0.04%
  • Vanguard Balanced Index Inv
    19.84K0.03%
  • Fidelity Nasdaq Composite Index
    14.33K0.02%